GlamCO 5-Amino-1MQ
99%+ Purity
Verified by HPLC
Home / Catalog / 5-Amino-1MQ

5-Amino-1MQ

$85.00
Made in USA
cGMP Compliant

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule, cell-permeable NNMT inhibitor for in vitro and preclinical research into NAD+ biology, adipocyte metabolism, and methyl-group dynamics.

Tier Quantity Discount
Most Popular 3 - 5 10%
Max Savings 6 + 15%
Secure Checkout | Third-Party Tested | Free Shipping $100+
Sterility & Endotoxins PASSED
Net Content & Purity PASSED
Third-Party Lab Verified

Independently Tested. Verifiably Pure.

Every batch of 5-Amino-1MQ is sent to an accredited independent laboratory before it ships. Here is exactly what we screen for - and the certificate that proves it.

What We Test Every Batch For

HPLC Purity Analysis
Confirms the peptide is ≥99% pure
Mass Spectrometry
Verifies the exact molecular identity
Heavy Metals Screening
Lead, arsenic, cadmium & mercury - Pass
Endotoxins (LPS)
Bacterial endotoxin levels - Pass
Sterility Testing
No microbial contamination - Pass
TFA Content
Residual trifluoroacetic acid - Not Detected
Net Peptide Content
Actual peptide mass per vial verified
🧪
1.2 μM
NNMT IC50
In vitro substrate-site inhibition
⚛️
C₁₀H₁₁N₂⁺
Small Molecule
Cell-permeable methylquinolinium
📄
2018
Key Preclinical Paper
Neelakantan et al., Biochem Pharmacol
🛡️
99%+
Purity Verified
HPLC tested, COA included
Molecular Mechanism

How 5-Amino-1MQ Works

NNMT inhibition studied across NAD+ biology, adipocyte metabolism, and methyl-group dynamics research models

NNMT Inhibition

Competitive NNMT Substrate Inhibitor

5-Amino-1MQ is a cell-permeable small molecule that binds the nicotinamide (substrate) pocket of nicotinamide N-methyltransferase (NNMT). It has been reported as a selective NNMT inhibitor with an in vitro IC50 near 1.2 uM, with no inhibition of other SAM-dependent methyltransferases or NAD+ salvage enzymes in published assays.

  • Substrate-site selective NNMT inhibition
  • Methylquinolinium scaffold permeates cell membranes
  • Used as a chemical probe of NNMT in vitro
NAD+ / SAM Cycle

Intracellular NAD+ and SAM Preservation

NNMT consumes S-adenosyl-L-methionine (SAM) and nicotinamide to produce 1-methylnicotinamide (MNA), a metabolic dead-end. In cultured adipocytes, NNMT inhibition with 5-Amino-1MQ has been reported to lower intracellular MNA and elevate intracellular NAD+ (Neelakantan et al., Biochem Pharmacol 2018), preserving methyl-donor and NAD+ pools available for sirtuin and methyltransferase activity.

  • Reduces MNA production in adipocyte cell culture
  • Increases intracellular NAD+ in vitro
  • Spares SAM for downstream methylation reactions
Adipocyte Metabolism

Lipogenesis and Energy Expenditure

In diet-induced obese mouse models, 5-Amino-1MQ administration has been reported to suppress lipogenic gene expression in white adipose tissue, decrease adipocyte size, and reduce body weight without changes in food intake (Neelakantan et al., 2018). These preclinical observations are consistent with a shift from lipid storage toward oxidation in adipocytes.

  • Suppressed adipocyte lipogenesis in research models
  • Reduced white adipose mass in preclinical mice
  • Studied as a chemical tool in NNMT/obesity research
Preclinical Findings

What Research Has Shown

Key findings from in vitro studies and preclinical mouse models

Body Weight Reduction in DIO Mice (11 days, in vivo) ~7%
White Adipose Mass Decrease (DIO mice) ~30%
NNMT IC50 in vitro (lower = more potent) ~1.2 μM
Food Intake in Treated Mice vs. Control Unchanged
Investigational Fields

Research Applications

Primary areas of 5-Amino-1MQ investigation

Adipocyte Biology

Adipocyte Metabolism Research

5-Amino-1MQ is used as a chemical probe of NNMT in cultured adipocytes and in diet-induced obese mouse models, where it has been reported to reduce adipocyte size, lower white adipose mass, and suppress lipogenic gene expression in vivo.

Neelakantan et al. 2018 ↗
NAD+ Biology

NAD+ Pathway Studies

By blocking NNMT-mediated consumption of nicotinamide, 5-Amino-1MQ is studied in cell culture systems exploring NAD+ salvage, sirtuin activity, and the interplay between NNMT expression and cellular energy status in adipose and liver models.

Roberti et al. 2021 ↗
Skeletal Muscle

Muscle Stem Cell & Aging Models

Preclinical work in aged mice reports that NNMT inhibition with 5-Amino-1MQ enhances muscle stem cell function, fiber regeneration, and contractile force in aged tibialis anterior, supporting its use as a tool compound in skeletal muscle aging research.

Neelakantan et al. 2019 ↗
Methyl-Group Dynamics

SAM/Methylation Research

Because NNMT is a major SAM consumer in adipose tissue, 5-Amino-1MQ is used to dissect the contribution of NNMT to intracellular SAM, S-adenosylhomocysteine (SAH), and histone methylation balance in metabolic disease research models.

Kraus et al. 2014 ↗
Technical Specifications

Compound Information

Technical specifications and analytical profile

Chemical Name
5-Amino-1-methylquinolinium (5-Amino-1MQ)
Compound Class
Small-molecule NNMT inhibitor (methylquinolinium scaffold)
Molecular Formula (cation)
C₁₀H₁₁N₂⁺
Molecular Weight (cation)
~159.2 g/mol (free cation); iodide salt ~286 g/mol
CAS Number
42464-96-0 (iodide salt commonly cataloged)
NNMT IC50 (in vitro)
~1.2 μM, substrate-site selective
Form
Lyophilized powder
Purity
≥99% (HPLC verified)
Testing
Third-party HPLC, Mass Spec, Endotoxin
Storage (lyophilized)
2-8°C short-term; -20°C for long-term stability
Storage (reconstituted)
2-8°C, protect from light, use within 14 days
Solubility
Water-soluble; bacteriostatic water for reconstitution
COA
Included with every order
Common Inquiries

Frequently Asked Questions

Common questions about 5-Amino-1MQ research parameters

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). It was characterized as a substrate-site selective NNMT inhibitor with an in vitro IC50 near 1.2 uM. This material is supplied as a research chemical for in vitro and preclinical laboratory research use only.
NNMT methylates nicotinamide using S-adenosyl-L-methionine (SAM) to generate 1-methylnicotinamide (MNA), a stable metabolic dead-end. Each catalytic cycle consumes one SAM and one nicotinamide that would otherwise feed back into the NAD+ salvage pathway. In published cell-culture work, 5-Amino-1MQ blocked this reaction, reduced intracellular MNA and increased intracellular NAD+ in adipocytes, providing a chemical tool to study NNMT's role in NAD+ and SAM/methylation biology.
Published work has used 5-Amino-1MQ in cultured adipocytes (e.g., 3T3-L1 and primary cells) to probe lipogenesis and NAD+ flux, in diet-induced obese (DIO) mouse models of obesity to study white adipose mass and adipocyte size, and in aged mouse skeletal muscle preparations to investigate NNMT's role in muscle stem cell function. All such work is preclinical / laboratory research.
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that is highly expressed in white adipose tissue and liver and is up-regulated in obesity and type 2 diabetes in both human and rodent studies. Kraus et al. (Nature, 2014) showed that adipose NNMT knockdown protected mice from diet-induced obesity, identifying NNMT as a node coupling methyl-group metabolism, NAD+ and energy expenditure. 5-Amino-1MQ is one of the most widely used small-molecule tools to interrogate that biology in vitro.
Lyophilized 5-Amino-1MQ is typically stored at 2-8°C for short-term laboratory storage and at -20°C for long-term storage, protected from light and moisture. The compound is water-soluble and is commonly reconstituted in sterile or bacteriostatic water for in vitro work; reconstituted solutions are stored refrigerated at 2-8°C and used within ~14 days. Always follow your institution's standard handling procedures for research chemicals.
No. 5-Amino-1MQ is an experimental NNMT inhibitor used as a chemical tool in preclinical research. It is not an approved drug and is not intended for human or veterinary use. Material from GlamCO is supplied strictly for in vitro and laboratory research use only.
Academic Literature

Sources & References

Peer-reviewed publications and clinical studies database

NATURE

Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity

2014 · Kraus D et al., Nature 508:258-262
View Source ↗
PUBMED

Selective inhibition of NNMT by small molecules favourably modulates adipocyte phenotype in vivo

2018 · Neelakantan H et al., Biochem Pharmacol
View Source ↗
PUBMED

Small molecule NNMT inhibitor reverses adipose-tissue NNMT-induced obesity and metabolic dysregulation

2019 · Neelakantan H et al., Biochem Pharmacol
View Source ↗
PMC

Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes

2021 · Roberti A et al., Biomolecules
View Source ↗
PUBMED

Structure-activity relationships and discovery of a 1-methylquinolinium NNMT inhibitor

2017 · Neelakantan H et al., J Med Chem / Bioorg Med Chem Lett
View Source ↗
FRONTIERS

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome

2024 · Frontiers in Pharmacology
View Source ↗